Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Feb 26, 2023; 15(2): 64-75
Published online Feb 26, 2023. doi: 10.4330/wjc.v15.i2.64
Published online Feb 26, 2023. doi: 10.4330/wjc.v15.i2.64
Safety and efficacy of balloon angioplasty compared to stent-based-strategies with pulmonary vein stenosis: A systematic review and meta-analysis
Pradyumna Agasthi, Pattara Rattanawong, Nithin Venepally, Chieh-Ju Chao, Hasan Ashraf, Sai Harika Pujari, Mohamed Allam, Amit Kumar, Farouk Mookadam, Floyd David Fortuin, Reza Arsanjani, Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ 85259, United States
Srilekha Sridhara, Department of Internal Medicine, Banner Heart Hospital, Mesa, AZ 85054, United States
Diana Almader-Douglas, Library Services, Mayo Clinic, Phoenix, AZ 85054, United States
Yamini Alla, Department of Medicine, Bronx Lebanon Hospital, Bronx, NY 10457, United States
Douglas L Packer, David R Holmes Jr, Donald J Hagler, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, United States
Author contributions: Agasthi P and Sridhara S contributed equally to this work; Agasthi P, Sridhara S, Mookadam F, Fortuin FD and Arsanjani R, designed the research study; Agasthi P, Sridhara S, Rattanawong P, Venepally NR, Chao C, Ashraf H and Pujari S performed the research; Douglas DA, Allam Mohamed, Alla Y, Kumar A contributed new reagents and analytic tools; Agasthi P, Sridhara S, Rattanawong P, Venepally NR, Chao C, Ashraf H, Pujari S and Allam M analyzed the data and wrote the manuscript; Mookadam F, Packer DL, Holmes DR Jr, Hagler DJ, Fortuin FD and Arsanjani R reviewed the manuscript before submission; All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors received no financial support for the research, authorship, and/or publication of this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Nithin Venepally, MD, Academic Research, Department of Cardiovascular Diseases, Mayo Clinic, 5777 E Mayo Blvd, Scottsdale, AZ 85259, United States. nrvenepally@gmail.com
Received: September 19, 2022
Peer-review started: September 19, 2022
First decision: November 2, 2022
Revised: November 17, 2022
Accepted: February 8, 2023
Article in press: Feburary 8, 2023
Published online: February 26, 2023
Processing time: 155 Days and 3.5 Hours
Peer-review started: September 19, 2022
First decision: November 2, 2022
Revised: November 17, 2022
Accepted: February 8, 2023
Article in press: Feburary 8, 2023
Published online: February 26, 2023
Processing time: 155 Days and 3.5 Hours
Core Tip
Core Tip: 81.5% of patients with pulmonary vein stenosis undergoing a transcatheter intervention reported symptom of dyspnea. Pulmonary vein stent implantation (PSI) was superior to pulmonary vein balloon angioplasty (PBA) in preventing restenosis of the pulmonary vein. No difference in procedural related complications was noted between PSI and PBA. Differences in peri-procedural anticoagulation strategies between studies could have affected the outcome.